Article citationsMore>>

Nitti, V.W., Chapple, C.R., Walters, C., Blauwet, M.B., Herschorn, S., Milsom, I., Auerbach, S. and Radziszewski, P. (2014) Safety and Tolerability of the β3-Adrenoceptor agonist Mirabegron, for the Treatment of Overactive Bladder: Results of a Prospective Pooled Analysis of Three 12-Week Randomised Phase III Trials and of a 1-Year Randomised Phase III Trial. International Journal of Clinical Practice, 68, 972-985.
https://doi.org/10.1111/ijcp.12433

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top